We found that only the broad-spectrum PIs stabilize the DCL1 protein, whereas the proteasome-specific inhibitors MG132, MG115, and CLL have no stabilizing effect on the protein (Fig 3A). This evidence concerns the gene CD302 and B-cell chronic lymphocytic leukemia.